Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy

Advanced non-small-cell lung cancer (NSCLC) remains a challenging disease. The limited utility of chemotherapy indicates the need for additional therapeutic options. Targeted therapy continues to be an important tool in the treatment of NSCLC. Mutations within the RAS–RAF–MEK–MAPK pathway, specifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Weart, Thomas C, Miller, Kenneth D, Simone, Charles B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892608/
https://www.ncbi.nlm.nih.gov/pubmed/29662327
http://dx.doi.org/10.2147/CMAR.S142269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892608/
https://www.ncbi.nlm.nih.gov/pubmed/29662327
http://dx.doi.org/10.2147/CMAR.S142269

Ejemplares similares